ARTICLE | Regulation

Califf, biopharma industry leaders support accelerated approval reforms

Califf, GSK’s Barron, BIO’s McMurry-Heath say centralized data collection is needed

January 12, 2022 1:49 AM UTC

Rob Califf, President Joe Biden’s nominee for FDA commissioner, has publicly endorsed the accelerated approval pathway, called for redoubling efforts to confirm clinical efficacy, and backed ...

Access this Article